House Committee Advances Bill to Add Synthetics to Schedule I of Controlled Substances Act
The House Energy and Commerce Committee on Sept. 21 by unanimous voice vote reported out the Synthetic Drug Control Act of 2015, which would add several synthetic drug compounds to Schedule I of the Controlled Substances Act. The original legislation…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
(H.R. 3537) (here) proposes to add 121 phenylalkylamines, 117 “cannabimimetic agents,” 16 arylcyclohexamines, 26 tryptamines, five benzodiazepines, 13 “opioids and opioid-like substances,” eight piperazines and two tropane alkaloids to Schedule I. Further, the committee by voice vote during markup adopted an amendment to the bill to add 22 more synthetic substances, including 11 more cannabimimetic agents, and three derivatives of fentanyl, to Schedule I. The additions would take effect 30 days after the bill’s enactment. The legislation now goes to the full House for consideration.